In 1993, only 16,800 procedures were reported. That number jumped to 370,000 in 2009. Once offered only to patients who needed to lose more than 100 pounds, concerns about obesity-related conditions, such as diabetes and heart disease, have opened the procedure up to patients with a BMI as low as 30. An increase in cancer diagnoses and procedures is also expected to contribute to market growth.
Related Articles on Gastroenterology:
EndoChoice to Receive Georgia Bio Deal of the Year Award
Gastrointestinal Endoscopic Device Market Expected to Hit $2.7B by 2018
KY’s Jennie Stuart ASC Celebrates 5th Anniversary, Adds Barrett’s Esophagus Treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
